Retrospective Study
Copyright ©The Author(s) 2016.
World J Diabetes. Dec 15, 2016; 7(20): 621-626
Published online Dec 15, 2016. doi: 10.4239/wjd.v7.i20.621
Table 2 Characteristics of the patients are shown based on the presence or absence of auto-antibodies and the C-peptide secretion
Auto-antibodiesAb+Ab-
C-peptide secretionβ- (G 1)β+ (double diabetes)β- (G2)β+
Age of diagnosis13.16a15.316.617.02e
Family history of diabetes24 (13.5%)45 (25.3%)14 (7.9%)95 (53.4%)e
Family history of auto immune disease32 (44.4%)a28 (38.8%)5 (6.9%)7 (9.7%)e
History of auto immune disease29 (51.7%)a17 (30.4%)2 (3.6%)8 (14.3%)e
DKA at presentation57 (46.7%)a33 (27%)5 (4%)27 (22.1%)e
BMI (kg/m2)21a26.824.229.6e
HbA1c (%)10.2a8.910.811.7e
Patients requiring insulin at diagnosis65 (22.6%)a90 (31.4%)28 (9.8%)104 (36.2%)
Patients requiring insulin multiple dose injection (follow-up)65 (44.2%)a31 (21%)28 (19%)c23 (15.6%)e
Patients on metformin only during follow-up0a48 (38.1%)0c78 (61.9%)e
Patients on metformin with insulin during follow-up4 (6.1%)a27 (41.5%)2 (3.1%)c32 (49.2%)